Probe Finds No HQ Instruction for Improper Patient Info Acquisition in Xarelto Surveys, Bayer Execs Take 3-Month Pay Cuts

Bayer Holdings (Japan) President Hans-Dieter Hausner (left), Bayer Yakuhin President Heike Prinz at Tokyo Press Conference No instruction from Bayer Yakuhin’s Osaka headquarters existed in the improper acquisition of patient information during surveys related to its flagship anticoagulant Xarelto (rivaroxaban),...read more